The History of Stem Cells & Regenerative Medicine

August 28, 2015

The infographic way of explaining the stem cells regenerative medicine is really a big help for many people so that it can be easily understand.Regenerative Medicine encompasses many fields of science and medicine.  The image below effectively portrays the scope of Regenerative Medicine; as the umbrella, it covers many fields of research and clinical practice. Stem cell research and therapies continue to enhance the field of Regenerative Medicine and what it offers patients and scientists.

Spotlight

APEIRON Biologics

Apeiron Biologics AG is a privately financed Biotech company in Vienna, Austria. The company currently employs around 25 people and has a strong focus on immunological approaches to treat cancer. In 2010, Apeiron out-licensed itslead project (a recombinant enzyme for the treatment of Acute Respiratory Distress Syndrome and other diseases) to GSK in a deal potentially worth €236 million. Subsequently, Apeiron in-licensed several clinical projects (a liposomal formulation of SOD, a fusion protein and a monoclonal antibody against neuroblastoma) to complement its innovative in-house projects

Other Infographics
news image

Designing Genetic Circuit

Infographic | April 13, 2020

Near the turn of the millennium, James Collins and Stanislas Leibler independently undertook rather similar projects: design what would become synthetic biology’s seminal genetic circuits. And they came up with strikingly similar action plans—use E. coli to pair promoters with repressors that control one another’s behavior.

Read More
news image

RNA sequencing libraries

Infographic | April 7, 2020

As part of our In Focus on RNA sequencing for cancer research, we put together an infographic to provide top tips on the preparation of RNA sequencing libraries, the best metrics to use when analyzing your libraries and suggestions for efficient and effective kits for the preparation of each library type.

Read More
news image

What Paraspeckles Can Teach Us About Basic Cell Biology

Infographic | December 1, 2019

Discovering a new type of subnuclear body taught me how pursuing the unexpected can lead to new insights—in this case, about long noncoding RNAs and liquid-liquid phase separation in cells.

Read More
news image

Merck’s 23 CRISPR Patents Leading the way in genome-editing technology

Infographic | April 7, 2020

CRISPR Integration: CRISPR/Cas9 System for insertion in eukaryotic cells Compositions and use of CRISPR/Cas9 to integrate a new sequence of DNA after cutting genomic DNA. CRISPR-chrom: Improves access to the genome so that CRISPR-driven edits can be done more efficiently.

Read More
news image

Next-Gen Genetics: Cancer Therapies Create Investment Prospects

Infographic | August 12, 2022

The field (gene therapy) is not standing still, it’s evolving rapidly. If we have this discussion again in 18 months’ time, I don't know what we’ll be using then.

Read More
news image

The COVID-19 pandemic has swept the globe, yet many people still do not understand how it affects the body

Infographic | April 16, 2020

The COVID-19 pandemic has swept the globe, yet many people still do not understand how it affects the body. This infographic shows the events that occur following SARS-CoV-2 infection

Read More

Spotlight

APEIRON Biologics

Apeiron Biologics AG is a privately financed Biotech company in Vienna, Austria. The company currently employs around 25 people and has a strong focus on immunological approaches to treat cancer. In 2010, Apeiron out-licensed itslead project (a recombinant enzyme for the treatment of Acute Respiratory Distress Syndrome and other diseases) to GSK in a deal potentially worth €236 million. Subsequently, Apeiron in-licensed several clinical projects (a liposomal formulation of SOD, a fusion protein and a monoclonal antibody against neuroblastoma) to complement its innovative in-house projects

Events